Serum Ghrelin in Polycystic Ovary Syndrome

N/AUnknownNCT02087410

amr hesham el etreby84 enrolled

Overview

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

two groups one healthy and other with pco measure ghrelin level in both of them to find relation between pco and ghrelin

Study Type

OBSERVATIONAL

Enrollment

Conditions

Polycystic Ovary

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria:pco women * At least 12 months of infertility. * Patients with polycystic ovarian syndrome according to Rotterdam criteria: Exclusion Criteria: * Patients with hyperprolactinemia * Patients with Cushing's syndrome * Patients with Congenital or non-classical adrenal hyperplasia * Patients with hormone secreting tumors. * Patients with hormonal treatment in the last 3 months.

Locations (1)

Maternity Hospital

Cairo, Cairo Governorate, Egypt

Outcomes

Primary Outcomes

relationships between circulating ghrelin and the clinical and biochemical manifestations of PCOS

Analysis of levels of ghrelin in study group

Time frame: after 6 monthes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.